![]() |
Leukemia |
Free Subscription
1 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
MRD Assessment in Patients With Acute Myeloid Leukemia Aged >/= 60 Years Treated
With a 10-Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21
Study.
Am J Hematol. 2025 Jul 1. doi: 10.1002/ajh.27763.
PubMed
Second allogeneic transplantation in relapsed acute leukemia - a risk worth
taking?
Ann Hematol. 2025 Jul 3. doi: 10.1007/s00277-025-06468.
PubMed
Abstract available
Clinical significance of C-reactive protein/platelet ratio from diagnosis to
allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Ann Hematol. 2025 Jul 3. doi: 10.1007/s00277-025-06470.
PubMed
Abstract available
TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute
myeloid leukemia.
Ann Hematol. 2025 Jul 1. doi: 10.1007/s00277-025-06494.
PubMed
First report of B-lymphoblastic leukemia harboring LRRFIP1::FGFR1 fusion:
expanding the clinical spectrum of myeloid/lymphoid neoplasms with tyrosine
kinase gene fusions.
Ann Hematol. 2025 Jun 30. doi: 10.1007/s00277-025-06481.
PubMed
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia.
Blood. 2025 Jul 3:blood.2025028935. doi: 10.1182/blood.2025028935.
PubMed
Abstract available
Therapy-related juvenile myelomonocytic leukemia.
Blood. 2025;146:127.
PubMed
Chronic myeloid leukemia outcomes according to baseline risk and first-line
treatment in real-world settings: Data from the Italian Network/CML Campus.
Cancer. 2025;131:e35963.
PubMed
Abstract available
Treatment Free Remission (TFR) in Chronic Phase-Chronic Myeloid Leukemia
(CP-CML): Analysis of Predictive Factors and Novel Baseline Scoring System to
Predict Molecular Relapse.
Eur J Haematol. 2025 Jun 30. doi: 10.1111/ejh.70006.
PubMed
Abstract available
Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults
Exhibit Distinct Genetic Profiles.
Eur J Haematol. 2025;115:185-192.
PubMed
Abstract available
Genetic Landscape and Risk Stratification of AML With Hyperdiploid Karyotype.
Eur J Haematol. 2025;115:165-175.
PubMed
Abstract available
Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and
AML cells.
Exp Hematol. 2025;147:104790.
PubMed
Abstract available
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
Hematol Oncol Clin North Am. 2025 Jun 30:S0889-8588(25)00064.
PubMed
Abstract available
The role of leukapheresis in managing complications of hyperleukocytosis in
pediatric acute leukemia.
Int J Hematol. 2025 Jun 30. doi: 10.1007/s12185-025-04027.
PubMed
Abstract available
CML stem cells and their interactions and adaptations to tyrosine kinase
inhibitors.
Leuk Lymphoma. 2025;66:1211-1220.
PubMed
Abstract available
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the
role of early bone marrow assessment.
Leukemia. 2025 Jul 3. doi: 10.1038/s41375-025-02675.
PubMed
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for
adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic
leukemia: a single-center, single-arm, phase 2 trial.
Leukemia. 2025 Jun 30. doi: 10.1038/s41375-025-02674.
PubMed
Abstract available
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced
elimination of acute myeloid leukemia cells.
Leukemia. 2025 Jun 30. doi: 10.1038/s41375-025-02673.
PubMed
Abstract available
Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell
lymphoma responders, a rising risk over time?
Leukemia. 2025 Apr 24. doi: 10.1038/s41375-025-02605.
PubMed
Abstract available
[Corrigendum] Overexpression of IL?9 induced by STAT3 phosphorylation is mediated
by miR?155 and miR?21 in chronic lymphocytic leukemia.
Oncol Rep. 2025;54:107.
PubMed
Abstract available
Bioinformatics-guided construction of a tumor microenvironment-derived prognostic
model in acute myeloid leukemia.
PLoS One. 2025;20:e0325145.
PubMed
Abstract available
Survival analysis and clinical abnormalities in cats with progressive or
regressive feline leukemia virus (FeLV) infection in Brazil.
PLoS One. 2025;20:e0322691.
PubMed
Abstract available
Thank you for your interest in scientific medicine.